|
79
|
346
|
8xj4A |
Structure of prostatic acid phosphatase in human semen |
|
173
|
524
|
7bbjA |
Cd73 in complex with the humanized antagonistic antibody mab19 |
|
188
|
523
|
7qglA |
Human cd73 (ecto 5'-nucleotidase) in complex with mrs4602 (a 3-methyl-cmpcp derivative, compound 21 in paper) in the open state |
|
139
|
523
|
7qgmA |
Human cd73 (ecto 5'-nucleotidase) in complex with mrs4598 (a 3-methyl-cmpcp derivative, compound 16 in paper) in the closed state (crystal form iii) |
|
189
|
523
|
7qgaA |
Human cd73 (ecto 5'-nucleotidase) in complex with mrs4598 (a 3-methyl-cmpcp derivative, compound 16 in paper) in the open state |
|
173
|
523
|
7qgoA |
Human cd73 (ecto 5'-nucleotidase) in complex with mrs4602 (a 3-methyl-cmpcp derivative, compound 21 in paper) in the closed state (crystal form iii) |
|
109
|
292
|
7zeeA |
Human cytosolic 5' nucleotidase iiib |
|
5
|
36
|
7zzvA |
Prostatic acid phosphatase (pap) fragment (85-120) |
|
106
|
289
|
7zegA |
Human cytosolic 5' nucleotidase iiib in complex with 3,4-dif-bn7gmp |
|
99
|
285
|
7zehA |
Human cytosolic 5' nucleotidase iiib in complex with 3,4-dif-bn7guanine |
|
181
|
524
|
7p9tA |
Crystal structure of cd73 in complex with dcmp in the open form |
|
187
|
524
|
7pd9A |
Crystal structure of cd73 in complex with riboflavin in the open form |
|
182
|
524
|
7p9rA |
Crystal structure of cd73 in complex with gmp in the open form |
|
185
|
524
|
7pbbA |
Crystal structure of cd73 in complex with caffeine in the open form |
|
186
|
524
|
7pcpA |
Crystal structure of cd73 in complex with 5-iodouracil in the open form |
|
185
|
524
|
7pbaA |
Crystal structure of cd73 in complex with imp in the open form |
|
185
|
524
|
7pbyA |
Crystal structure of cd73 in complex with 4-nitrocatechol in the open form |
|
184
|
524
|
7pb5A |
Crystal structure of cd73 in complex with ump in the open form |
|
186
|
524
|
7p9nA |
Crystal structure of cd73 in complex with amp in the open form |
|
184
|
524
|
7pa4A |
Crystal structure of cd73 in complex with cmp in the open form |
|
157
|
523
|
6vcaA |
Tb38 complex |
|
171
|
523
|
6vc9A |
Tb19 complex |
|
166
|
524
|
6ye1A |
Human ecto-5'-nucleotidase (cd73) in complex with the ampcp derivative a894 (compound 2n in publication) in the closed form (crystal form iv) |
|
172
|
524
|
6ye2A |
Human ecto-5'-nucleotidase (cd73) in complex with the ampcp derivative a1202 (compound 4a in publication) in the closed form (crystal form iv) |
|
163
|
526
|
6s7hA |
Human cd73 (5'-nucleotidase) in complex with psb12489 (an aopcp derivative) in the closed state |
|
162
|
526
|
6s7fA |
Human cd73 (5'-nucleotidase) in complex with psb12379 (an aopcp derivative) in the closed state |
|
179
|
524
|
6z9bA |
Human ecto-5'-nucleotidase (cd73) in complex with aopcp derivative a830 (compound 16 in publication) in the closed form (crystal form iii) |
|
116
|
422
|
6rnhA |
Structure of c-terminal truncated plasmodium falciparum imp-nucleotidase |
|
137
|
430
|
6rmoA |
Structure of plasmodium falciparum imp-nucleotidase |
|
162
|
435
|
6rmdA |
Structure of atp bound plasmodium falciparum imp-nucleotidase |
|
112
|
384
|
6rmeA |
Structure of imp bound plasmodium falciparum imp-nucleotidase mutant d172n |
|
123
|
394
|
6rmeC |
Structure of imp bound plasmodium falciparum imp-nucleotidase mutant d172n |
|
109
|
388
|
6rmeF |
Structure of imp bound plasmodium falciparum imp-nucleotidase mutant d172n |
|
129
|
372
|
6rmdD |
Structure of atp bound plasmodium falciparum imp-nucleotidase |
|
121
|
386
|
6rmeE |
Structure of imp bound plasmodium falciparum imp-nucleotidase mutant d172n |
|
106
|
385
|
6rmeB |
Structure of imp bound plasmodium falciparum imp-nucleotidase mutant d172n |
|
98
|
372
|
6rn1A |
Structure of n-terminal truncated plasmodium falciparum imp-nucleotidase |
|
97
|
385
|
6rmwA |
Structure of n-terminal truncated imp bound plasmodium falciparum imp-nucleotidase |
|
160
|
486
|
6fiuA |
Human cytosolic 5'-nucleotidase ii soaked with 10mm 2-(6-([1,1'-biphenyl]-3-carboxamido)-9h-purin-9-yl)acetic acid |
|
161
|
486
|
6fiwA |
Human cytosolic 5'-nucleotidase ii co-crystallized with 10mm sodium ((4-(3'-((7h-purin-6-yl)carbamoyl)-[1,1'-biphenyl]-3-yl)-1h-imidazol-1-yl) methyl) phosphonate |
|
160
|
488
|
6fxhA |
Human cytosolic 5'-nucleotidase ii soaked with 10mm 3-phenyl-n-(9h-purin-6-yl)benzamide |
|
162
|
486
|
6fisA |
Human cytosolic 5'-nucleotidase ii soaked with 10mm 7-benzyloxymethyl-7h-adenine |
|
158
|
487
|
6firA |
Human cytosolic 5'-nucleotidase ii soaked with 5mm3-phenyl-n-(9h-purin-6-yl)benzamide |
|
161
|
486
|
5l50A |
Crystal structure of enzyme in purine metabolism |
|
77
|
259
|
5kstA |
Stationary phase survival protein e (sure) from xylella fastidiosa- xfsure-tsamp (tetramer smaller - crystallization with 3'amp). |
|
160
|
486
|
5l4zA |
Crystal structure of enzyme in purine metabolism |
|
68
|
255
|
5kssA |
Stationary phase survival protein e (sure) from xylella fastidiosa - xfsure-ds (dimer smaller) |
|
159
|
486
|
5k7yA |
Crystal structure of enzyme in purine metabolism |
|
159
|
486
|
6de2A |
Crystal structure of the double mutant (d52n/l375f) of the full-length nt5c2 in the active state |
|
164
|
486
|
6ddhA |
Crystal structure of the double mutant (d52n/r367q) of nt5c2-537x in the active state, northeast structural genomics target |
